Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aviron FluMist Annual Release Tests In Human Subjects May Be Required

Executive Summary

FDA may require Aviron to conduct release tests in human subjects to ensure attenuation of FluMist before each flu season, the company indicated.

You may also be interested in...



FluMist Comparison To Inactivated Vaccine Suggested By FDA Committee

MedImmune should conduct head-to-head comparisons of its live intranasal flu vaccine FluMist and the marketed trivalent inactivated vaccine, FDA's Vaccine & Related Biological Drug Products Advisory Committee suggested Dec. 17

FluMist Comparison To Inactivated Vaccine Suggested By FDA Committee

MedImmune should conduct head-to-head comparisons of its live intranasal flu vaccine FluMist and the marketed trivalent inactivated vaccine, FDA's Vaccine & Related Biological Drug Products Advisory Committee suggested Dec. 17

Kaiser FluMist Safety Data Analysis To Be Submitted To FDA By Year-End

Aviron expects to submit to FDA the full analysis of a FluMist pediatric safety study conducted at Kaiser Permanente outpatient clinics by the end of the year.

Related Content

UsernamePublicRestriction

Register

PS038281

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel